James Cancer Hospital and Solove Research Institute Ohio State — Columbus, Ohio

James Cancer Hospital and Solove Research Institute Ohio State is a clinical research site located in Columbus, Ohio, United States 43210.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

James Cancer Hospital and Solove Research Institute Ohio State has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Chronic Myelogenous Leukemia - Chronic Phase, Melanoma, Non Small Cell Lung Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for James Cancer Hospital and Solove Research Institute Ohio State?

James Cancer Hospital and Solove Research Institute Ohio State has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has James Cancer Hospital and Solove Research Institute Ohio State conducted?

James Cancer Hospital and Solove Research Institute Ohio State has 2 clinical trials on record, with 2 currently active. Their work covers Chronic Myelogenous Leukemia - Chronic Phase, Melanoma, Non Small Cell Lung Cancer.

Is James Cancer Hospital and Solove Research Institute Ohio State accredited by Crixeo Health?

James Cancer Hospital and Solove Research Institute Ohio State has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about James Cancer Hospital and Solove Research Institute Ohio State?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.